Levocetirizine Dihydrochloride Tablet
Product Images NDC 51655-564

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 51655-564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 564 52 Master Bottle Label Approval Rev B 02 22)

Label for levocetirizine dihydrochloride tablets, USP 5 mg, oral tablet dosage form. The label indicates a package of 30 tablets, prescription only, manufactured by Northwind Pharmaceuticals, Inc. It includes storage instructions and a barcode. The label also contains lot information and expiration placeholders.*

FDA Label Image

Chemical Structure (Levocetirizine Structure)

Chemical structure of levocetirizine dihydrochloride showing its molecular arrangement, including aromatic rings, a piperazine ring, and hydrochloride salts indicated by .2HCl.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.